NCT06444542View on ClinicalTrials.gov

Understanding Patient Preference on Colorectal Cancer Screening Options-PSU

RecruitingOBSERVATIONAL

Enrollment

900

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2026

Conditions

Colo-rectal Cancer

Interventions

BEHAVIORAL

Guardant Shield

Blood-based colorectal cancer screening

Trial Locations (1)

17033

RECRUITING

Penn State College of Medicine, Hershey

Sponsors

Collaborators (1)

Guardant Health, Inc.

All Listed Sponsors

collaborator

Guardant Health, Inc.

INDUSTRY

collaborator

HealthLinc, Inc

UNKNOWN

collaborator

PCC Community Wellness Center

UNKNOWN

lead

Milton S. Hershey Medical Center

OTHER

NCT06444542 - Understanding Patient Preference on Colorectal Cancer Screening Options-PSU | Biotech Hunter | Biotech Hunter